Raymond James Financial Services Advisors’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-113,883
| Closed | -$2.69M | – | 3530 |
|
|
2023
Q4 | $2.69M | Buy |
113,883
+12,554
| +12% | +$224K | ﹤0.01% | 1412 |
|
|
2023
Q3 | $1.51M | Buy |
101,329
+3,434
| +4% | +$45.5K | ﹤0.01% | 1666 |
|
|
2023
Q2 | $1.07M | Buy |
97,895
+37,736
| +63% | +$351K | ﹤0.01% | 1892 |
|
|
2023
Q1 | $525K | Buy |
+60,159
| New | +$482K | ﹤0.01% | 2304 |
|
|
2021
Q4 | – | Sell |
-11,091
| Closed | -$40K | – | 3465 |
|
|
2021
Q3 | $40K | Sell |
11,091
-4,829
| -30% | -$19K | ﹤0.01% | 3201 |
|
|
2021
Q2 | $69K | Buy |
+15,920
| New | +$70.6K | ﹤0.01% | 3185 |
|
|
2020
Q4 | – | Sell |
-44,598
| Closed | -$323K | – | 3110 |
|
|
2020
Q3 | $323K | Buy |
+44,598
| New | +$238K | ﹤0.01% | 2236 |
|
|
2020
Q1 | – | Sell |
-13,238
| Closed | -$26K | – | 2906 |
|
|
2019
Q4 | $26K | Buy |
+13,238
| New | +$49.7K | ﹤0.01% | 2796 |
|
|
2018
Q2 | – | Sell |
-14,422
| Closed | -$187K | – | 2870 |
|
|
2018
Q1 | $187K | Buy |
+14,422
| New | +$179K | ﹤0.01% | 2280 |
|